2.3.1.147: glycerophospholipid arachidonoyl-transferase (CoA-independent)
This is an abbreviated version!
For detailed information about glycerophospholipid arachidonoyl-transferase (CoA-independent), go to the full flat file.
Word Map on EC 2.3.1.147
-
2.3.1.147
-
arachidonic
-
phospholipase
-
platelet-activating
-
paf
-
transacylation
-
coa-dependent
-
plasmalogens
-
1-acyl
-
ethanolamine-containing
-
alkylacylglycerophosphocholine
-
arachidonylated
-
arachidonoyl-coa
-
arachidonate-containing
-
alkylacyl-gpc
-
ether-containing
-
3harachidonate
-
aa-containing
-
ionophore-stimulated
-
3hlyso-paf
-
pharmacology
-
medicine
- 2.3.1.147
-
arachidonic
- phospholipase
-
platelet-activating
- paf
-
transacylation
-
coa-dependent
- plasmalogens
-
1-acyl
-
ethanolamine-containing
-
alkylacylglycerophosphocholine
-
arachidonylated
- arachidonoyl-coa
-
arachidonate-containing
-
alkylacyl-gpc
-
ether-containing
-
3harachidonate
-
aa-containing
-
ionophore-stimulated
-
3hlyso-paf
- pharmacology
- medicine
Reaction
Synonyms
Acyltransferase, 1-alkylglycerophosphocholine, CoA-independent transacylase, CoA-IT, CoAIT, Coenzyme A-independent transacylase
ECTree
2.3.1.147 glycerophospholipid arachidonoyl-transferase (CoA-independent)Advanced search results
results (
results (Application
Application on EC 2.3.1.147 - glycerophospholipid arachidonoyl-transferase (CoA-independent)
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
top
APPLICATION 
ORGANISM
UNIPROT
COMMENTARY 
LITERATURE
medicine
-
disruption of arachidonic acid remodeling in a manner that increases intracellular arachidonic acid level involving inhibition of the enzyme may represent a novel therapeutic strategy to reduce cancer cell proliferation
pharmacology
-
the enzyme may be a new therapeutic target to regulate inflammatory mediators
